Background: Hepatitis B represents a major global health problem. Despite the high endemicity of 22 hepatitis B in Sub-Saharan Africa, little is known about the molecular characteristics of chronic 23 hepatitis B virus (HBV) infection in Africa, and there are very few published studies that describe 24 the genetic characteristics of HBV in asymptomatic adults in DRC. The present study aimed at 25 determining the molecular diversity of chronic HBV infection in voluntary blood donors in Kinshasa, 26
According to the World Health Organization, an estimated 257 million people live 46 with chronic hepatitis B infection [1] , which is characterized by the persistence of 47 hepatitis B surface antigen (HBsAg) in blood for a period of more than 6 months [2] . 48
About 15 to 40 % of HBV-infected patients develop cirrhosis, liver failure, or 49 hepatocellular carcinoma (HCC) [3, 4] . In 2015, about 887 000 people died from 50 end-stage liver disease or HCC [1] . The global prevalence of chronic HBV infection, 51 defined as the prevalence of HBsAg, varies widely worldwide. Sub-saharan Africa 52 have the highest rates, since more than 8 % of the population in these regions have 53 chronic HBV infection [5] . 54 55 Owing to the high genetic variability of HBV, eight confirmed HBV genotypes 56 designated A to H, two tentative genotypes named I and J, and around forty sub-57 genotypes have been described [6] . The HBV genotypes and subgenotypes are 58 characterized by a minimum sequence divergence of 7.5 and 4 % of the entire 59 genome, respectively [6] [7] [8] The nucleotide sequences obtained were submitted to GenBank and were given the 144 accession numbers from KR535608 to KR535622 (Table S1) 
Results
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In the present study, the presence of HBsAg was detected in blood donors, using 156 ELISA. A total of 582 blood donors including 503 men (86.4 %) and 79 (13.6 %) 157 women were enrolled. Among the 582 blood donors, 40 (6.9 %) were positive for 158
HBsAg. The median age of blood donors was 28 years (ranged from 18-64 years). were obtained and were named beginning with "DRC-Kin" followed by study 171 identification numbers or letters, e.g. DRC-Kin-9126519 or using their accession 172 numbers (Table S1 ). Ten (66.7 %) out of the 15 new nucleotide sequences clustered 173 into genotype A. Four new nucleotide sequences (26.6 %) clustered into genotype E. 174
One (6.7%) nucleotide sequence clustered into genotype D. The new HBV/A 175 sequences belonged to quasi-subgenotype A3 (5/10), subgenotype A4 (3/10) and 176 subgenotype A1 (1/10). Majority of the new HBV strains were closely related either 7 to strains from DRC alone, or to strains from DRC and other African countries. One 178 of the new HBV/A sequences (KR535612 DRC) did not cluster with any HBV/A 179 subgenotype (Fig. 1) . 
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